Literature DB >> 30256383

A PEAR1 polymorphism (rs12041331) is associated with risk of coronary artery aneurysm in Kawasaki disease.

Lei Pi1, Yufen Xu1, Lanyan Fu1, Li Zhang2, Yunfeng Liu3, Huazhong Zhou1, Di Che1, Xiaoqiong Gu1,3.   

Abstract

Kawasaki disease (KD) is an acute systemic vasculitis that is most seriously complicated by coronary artery aneurysm (CAA). The polymorphisms of platelet endothelial aggregation receptor 1 (PEAR1), notably rs12041331 and rs12566888, were found to be closely related to cardiac disease. However, little is known regarding the connection between PEAR1 and KD. In this study, we genotyped PEAR1 rs12566888 and rs12041331 in 637 healthy infants and 694 KD patients (74 with CAA). Subsequently, odds ratio (OR) and 95% confidence interval (CI) were calculated to assess the strength of their relationships. No significant differences in the frequency of rs12566888 or rs12041331 in PEAR1 were observed between KD and healthy controls. However, regardless of the statistical combination of rs12566888 genotype, the rs12041331 recessive inheritance model was associated with an increased risk of CAA after Bonferroni correction (for rs12041331, AA vs. GG/GA: adjusted OR = 2.37, 95% CI = 1.41-4.01, P = 0.009; combination of two recessive genotypes vs. combination of 0-1 recessive genotypes: adjusted OR = 2.39, 95% CI = 1.42-4.04, P = 0.009). This study suggests for the first time that PEAR1 polymorphisms did not indicate susceptibility for KD occurrence but the rs12041331 polymorphism was associated with increased risk of CAA formation in KD, and the functions of the gene warrant further research.
© 2018 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  Kawasaki disease; coronary artery aneurysm; platelet endothelial aggregation receptor 1; polymorphisms

Mesh:

Substances:

Year:  2018        PMID: 30256383     DOI: 10.1111/ahg.12285

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  6 in total

Review 1.  PEAR1 polymorphisms as a prognostic factor in hemostasis and cardiovascular diseases.

Authors:  Narges Ansari; Sahar Najafi; Saied Shahrabi; Najmaldin Saki
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300

2.  Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly Population.

Authors:  Joshua P Lewis; Moeen Riaz; Sophia Xie; Galina Polekhina; Rory Wolfe; Mark Nelson; Andrew M Tonkin; Christopher M Reid; Anne M Murray; John J McNeil; Alan R Shuldiner; Paul Lacaze
Journal:  Clin Pharmacol Ther       Date:  2020-07-20       Impact factor: 6.875

3.  Impact of Platelet Glycoprotein Ia/IIa C807T Gene Polymorphisms on Coronary Artery Aneurysms of KD Patients.

Authors:  Wei Li; Lei Pi; Jia Yuan; Xueping Gu; Zhouping Wang; Yunfeng Liu; Qiulian Deng; Yanfei Wang; Ping Huang; Li Zhang; Xiaoqiong Gu
Journal:  Cardiol Res Pract       Date:  2021-02-23       Impact factor: 1.990

4.  Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study.

Authors:  Zekang Ye; Pengsheng Chen; Chuchu Tan; Xiaoxuan Gong; Ran Li; Zhou Dong; Inam Ullah; Chen Zhou; Sufeng Zhou; Lijun Xie; Xuemei Hou; Zhihui Han; Qian Gu; Jiazheng Ma; Jianzhen Teng; Yingdan Tang; Zhuanxia Zhang; Haitang Hu; Quankun Zhuang; Juan Chen; Bei Zhu; Feng Shao; Chunjian Li
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

5.  Variation of PEAR1 DNA methylation influences platelet and leukocyte function.

Authors:  Benedetta Izzi; Francesco Gianfagna; Wen-Yi Yang; Katrien Cludts; Amalia De Curtis; Peter Verhamme; Augusto Di Castelnuovo; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Jan A Staessen; Marc F Hoylaerts; Licia Iacoviello
Journal:  Clin Epigenetics       Date:  2019-10-29       Impact factor: 6.551

6.  FNDC1 Polymorphism (rs3003174 C > T) Increased the Incidence of Coronary Artery Aneurysm in Patients with Kawasaki Disease in a Southern Chinese Population.

Authors:  Kun Lin; Linyuan Zhang; Yishuai Wang; Jinqing Li; Yufen Xu; Di Che; Hanran Mai; Hongyan Yu; Lanyan Fu; Bing Wei; Zhiyong Jiang; Lei Pi; Xiaoqiong Gu
Journal:  J Inflamm Res       Date:  2021-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.